SEC Form 4 · accession 0001192482-17-000131
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Gordon Freund
Director · 10% Owner
Period of report
May 24, 2017
Accepted (ET)
May 25, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $9.33 | May 24, 2017 | A | 19,853 | A | — | May 24, 2027 | Common Stock | 19,853 | 19,853 | D |
Explanation of responses
- F1The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer.